Moreover, Mei Zhou et al. revealed that NGM282, an FGF19 analogue, regulated cholesterol in mice by activating MEK1 and reduced atherosclerosis in Apoe-/- mice with dyslipidaemia. This evidence concerns the gene APOE and atherosclerosis.